|
|
ClindamycinIf you do suspect an overdose, or if the medication has been ingested, call an emergency room or poison control left for advice. Azila bakri, social worker, ll women's action society awam ; belleza - wed jun 28, 2006 post subject: progesterex is a fictitious date rape drug, for instance, clindamycin 900. To the prescribing practitioner: This is not a complete list of medications covered by McLaren Health Plan. These medications, with a prescription, are readily available at participating pharmacies without any prior authorization requirement or step therapy protocols. If you need more information please call McLaren Health Plan for a complete list of non-formulary medications and formulary alternatives. Clindamycin suspension strengthDose of clindamycin for aspiration pneumoniaTopical preparations of metronidazole, clindamycin and erythromycin have been shown to be helpful for mild cases. Cefpodoxime proxetil.6 CEFTIN susp .6 CEFTIN tabs 125 mg .6 ceftriaxone .6 cefuroxime axetil.6 cefuroxime inj.6 CEFZIL.6 CELEBREX . 5, 12 CELLCEPT. 40 CELONTIN .8 CENESTIN . 37 cephalexin.6 CEREZYME . 32 chloroquine . 16 chlorpheniramine pseudoephedrine ext-rel 8 mg 120 mg. 44 CHLORPROMAZINE inj. 18 chlorpromazine tabs . 11, 18 chlorthalidone 25 mg, 50 mg, 100 mg. 26 chlorzoxazone. 47 cholestyramine . 26 CIALIS . 34 ciclopirox . 29 cilostazol. 23 CILOXAN oint. 42 cimetidine . 33 cimetidine inj. 33 CIPRO HC OTIC. 44 CIPRO inj .7 CIPRO susp .7 CIPRO tabs 100 mg .7 CIPRO XR.7 CIPRODEX . 44 ciprofloxacin . 7, 42 cisplatin . 15 citalopram . 10 cladribine . 15 CLARINEX . 44 clarithromycin.7 clemastine 2.68 mg . 44 CLEOCIN caps 75 mg .8 CLEOCIN PEDIATRIC.8 CLEOCIN vaginal supp .8 CLIMARA 0.0375 mg, 0.06 mg . 37 CLIMARA PRO . 37 clindamycin .8 53 and clotrimazole. APPENDIX XIII Antimicrobial Abbreviations Abbrevaitions - Antimicrobial Disks ANTIMICROBIAL Amikacin Amoxacillin Clavulanic Acid Ampicillin Aztreonam Cefazolin Cefepime Cefixime Cefotaxime Cefotetan Cefoxitin Ceftazidime Ceftriaxone Cefuroxime Cephalothin Cefpodoxime Chloramphenicol Ciprofloxacin Clarithromycin Clindammycin Colistin Cotrimoxazole Erythromycin Fusidic Acid Gentamicin Imipenem Levofloxacin Meropenem Metronidazole Minocycline Mupirocin Nalidixic Acid Nitrofurantoin Norfloxacin Novobiocin DISK Manufacturer ; AK Oxoid ; AMC AMP Oxoid ; ATM KZ Oxoid ; FEP CFM CTX CTT Gen. Diag. ; FOX Oxoid ; CAZ Oxoid ; CRO Oxoid ; CXM KF CPD C CIP Oxoid ; CLR DA Oxoid ; CT SXT Oxoid ; E Oxoid ; FD CN Oxoid ; IPM Difco ; LVX MEM MTZ Oxoid ; MH MUP NA F Oxoid ; NOR BBL or Difco ; NV Concentration ? g ; 30. CHC Iowa Drug Name cefadroxil cefazolin inj cefotaxime inj cefoxitin inj cefpodoxime proxetil CEFTIN SUSPENSION ceftriaxone cefuroxime cefuroxime axetil cephalexin cefprozil chloramphen inj CIPRO SUSPENSION CIPRO XR ciprofloxacin clarithromycin CLEOCIN CLEOCIN PED 3 CLEOCIN VAG 3 clindamycin CLINDESSE cortomycin DAPSONE DAYTON SULFA demeclocycline hcl dicloxacillin sodium DISPERMOX DORYX doxy-caps doxycycline hyclate doxycycline monohydrate DURICEF DYNABAC e.e.s. 200 suspension e.e.s. 400 E.E.S. GRAN ees sulfisox E-MYCIN ERY-TAB eryth sulfis ERYTHROCIN erythromycin FACTIVE FURADANTIN FUROXONE Drug Requirements Tier Limits 1 Drug Name GANTRIS PED garamycin inj gentamicin KETEK LEVAQUIN LEVAQUIN SOLN LORABID MANDELAMINE TAB MAXAQUIN MEPRON methenam hip methenam man metronidazol mhp-a minocycline MONODOX MONUROL nafcillin inj NEBUPENT NEGGRAM NEO-FRADIN neo poly hc neomycin NEOSPORIN GU SOLN NEUTREXIN nitrofur mac nitrofur mon ofloxacin OMNICEF oxacillin inj PANIXINE paromomycin PCE pencillin gk penicilln vk pen g sod inj PRIMSOL principen RANICLOR smz tmp ds smz-tmp inj smz-tmp grape suspension SPECTRACEF SULFADIAZINE Drug Requirements Tier Limits 3 1 and cutivate. Clindamycin colitisFolliculitis decalvans of the scalp is a recurrent, purulent follicular inflammation leading to scarring alopecia. We report on a 27-year-old man with folliculitis decalvans successfully treated with a combination of isotretinoin, corticosteroids, and clindamycin and cyproheptadine. Clindamycin urinary infections
ABILIFY Accutane * Acebutolol Acetazolamide Acetic Acid HC Otic Acetic Acid Otic Acetohexamide ACLOVATE ACTIVELLA ACTONEL ACTONEL WEEKLY ACTOS ACULAR Acyclovir Adalat * ADDERALL XR Adderall * ADRENALIN ADVAIR ADVICOR AEROBID-M AGENERASE AGGRENOX Akineton * AKNE-MYCIN ALBENZA Albuterol ALDACTAZIDE 50mg ALESSE ALKERAN Allopurinol ALOCRIL ALOMIDE ALPHAGAN P Alprazolam ALTACE ALUPENT 10mg ALUPENT MDI Amantadine AMARYL AMBIEN Amcinonide AMEVIVE AMICAR Amiloride Amiloride HCTZ Amino Acid Urea Aminophylline Amiodarone Amitrip Chlordiazepox Amitriptyline Amoxicillin Ampicillin Analpram-HC * ANDRODERM Anthralin Cream APAP Codeine M M ARANESP ARAVA ARICEPT ARIMIDEX ARMOUR THYROID ARTHROTEC ASACOL Aspirin Codeine Aspirin 800 CR Aspirin 975 EC ASTELIN Atenolol Atenolol Chlorthal Atropine Ophth ATROVENT MDI Augmentin * Auralgan * AVALIDE AVANDAMET AVANDIA AVAPRO AVC AVELOX AVONEX Aygestin * Azathioprine AZELEX AZMACORT AZOPT Azo-Sulfisoxazole AZULFIDINE EC Bacitracin Baclofen Bactrim * BACTROBAN CREAM BACTROBAN NASAL BECONASE Benazepril Benazepril & HCTZ BENICAR BENICAR HCT BENTYL SYRUP BENZACLIN Benzamycin Benzocaine Otic Benzocaine-Antipy-PE Benztropine Betamethasone Dip Betamethasone Val BETASERON Betaxolol Bethanechol BETOPTIC-S BIAXIN XL Biaxin * Bicitra * Bisoprolol P P Bisoprolol HCTZ BLEPHAMIDE OPTH Brontex * Bumetanide Bupropion Bupropion-SR Burrow's Soln. A.A. Buspirone Butalbital APAP CAFERGOT SUPP CALCIFEROL Calcitonin CAPITROL Captopril Captopril HCTZ CARAC CARAFATE SUSP Carbachol Ophth Carbamazepine CARBATROL Carbidopa Levodopa Carisoprodol Carisoprodol ASA Carteolol Ophth CASODEX CATAPRES-TTS CEDAX CEENU Cefaclor Cefadroxil Cefpodoxime Tab Ceftin * CEFZIL CELEBREX Celexa * CELLCEPT Cephalexin Cephradine CERUMENEX CETAPRED Chloral Hydrate Chloramphenicol Ophth Chlordiazepox Clindin Chlordiazepoxide Chlorhexidine Soln CHLOROPTIC Chloroquine 500mg Chlorothiazide Chlorpromazine Chlorpropamide Chlorthalidone 25mg Chlorthalidone 50mg Chlorzoxazone Cholestyramine Ciclopirox Lotion Cimetidine Ciprfloxacin P Prior Authorization M M CIPRO HC CIPRODEX Ciprofloxacin Ophth ; CLEOCIN 75MG CAP CLEOCIN PED SOLN CLEOCIN VAG CLIMARA 0.0375MG CLIMARA 0.06MG Climara * Clondamycin Clndamycin Gel Clindamhcin Lotion Clindamycln Sol Clindamycin Swab Clobetasol Clomipramine Clonazepam Clonidine Clonidine Chlorthal Clorazepate Clotrimazole Troche Cloxacillin Clozapine CODEINE SOL TAB CODEINE SOLN Codeine Sulf. Tab. COLAZAL Colchicine Colchicine Probenicid COLESTID COLYMYCIN-S COMBIVENT COMBIVIR COMPAZINE SYRUP CONCERTA COPAXONE COPEGUS Cophene #2 * COREG CORTEF 5mg CORTIFOAM Cortisone CORTISPORIN OPTH. Cortisporin Otic * CORZIDE COSOPT COZAAR CREON CRESTOR CRIXIVAN Cromolyn Neb Cromolyn Ophth CUPRIMINE Cyanocobalamin CYCLESSA Cyclobenzaprine CYCLOGYL 0.5.
26 Peterson HB, Walker CK, Kahn JG, Washington AE, Eschenbach DA, Faro S. Pelvic inflammatory disease: Key treatment issues and options. Journal of the American Medical Association 1991; 266 18 ; : 2605-2611. 27 Jadad A., Moore R., Carroll D. Assessing the quality of reports of randomised clinical trials: is blinding necessary? Controlled Clinical Trials 1996; 17: 1-12. Arredondo JL, Diaz V, Gaitan H, Maradiegue E, Oyarzun E, Paz R, et al. Oral clindamycin and ciprofloxacin versus intramuscular ceftriaxone and oral doxycycline in the treatment of mild-to-moderate pelvic inflammatory disease in outpatients. Clinical Infectious Diseases 1997; 24 2 ; : 170-178. 29 Bevan CD, Ridgway GL, Rothermel CD. Efficacy and safety of azithromycin as monotherapy or combined with metronidazole compared with two standard multidrug regimens for the treatment of acute pelvic inflammatory disease. Journal of International Medical Research 2003; 31: 45-54. Henry SA. Overall clinical experience with aztreonam in the treatment of obstetric-gynecologic infections. Reviews of Infectious Diseases 1985; 7 Suppl 4: S703-S708. 31 Larsen JW, Gabel-Hughes K, Kreter B. Efficacy and tolerability of imipenem-cilastatin versus clindamycin + gentamicin for serious pelvic infections. Clinical Therapeutics 1992; 14 1 ; : 90-96. 32 Hemsell DL, Little BB, Faro S, Sweet RL, Ledger WJ, Berkeley AS, et al. Comparison of three regimens recommended by the centers for disease control and prevention for the treatment of women hospitalized with acute pelvic inflammatory disease. Clinical Infectious Diseases 1994; 19 4 ; : 720-727. 33 Hemsell DL, Martens MG, Faro S, Gall S, McGregor JA. A multicenter study comparing intravenous meropenem with clindamcin plus gentamicin for the treatment of acute gynecologic and obstetric pelvic infections in hospitalized women. Clinical Infectious Diseases 1997; 24 SUPPL. 2 ; : S222-S230. 34 Maggioni P, Di Stefano F, Vacchini V, Irato S, Mancuso S, Colombo M, et al. Treatment of obstetric and gynecologic infections with meropenem: Comparison with imipenem cilastatin. Journal of Chemotherapy 1998; 10 2 ; : 114-121. 35 Martens MG, Gordon S, Yarborough DR, Faro S, Binder D, Berkeley A, et al. Multicenter randomized trial of ofloxacin versus cefoxitin and doxycycline in outpatient treatment of pelvic inflammatory disease. Southern Medical Association Journal 1993; 86 6 ; : 604-610. 36 Thadepalli H, Mathai D, Scotti R, Bansal MB, Savage E. Ciprofloxacin monotherapy for acute pelvic infections: A comparison with clindamydin plus gentamicin. Obstetrics & Gynecology 1991; 78 4 ; : 696702. 37 Walters MD, Gibbs RS. A randomized comparison of gentamicin-clindamycin and cefoxitin-doxycycline in the treatment of acute pelvic inflammatory disease. Obstetrics & Gynecology 1990; 75 5 ; : 867-872. 38 Wendel GD, Jr., Cox SM, Bawdon RE, Theriot SK, Heard MC, Nobles BJ. A randomized trial of ofloxacin versus cefoxitin and doxycycline in the outpatient treatment of acute salpingitis. American Journal of Obstetrics & Gynecology 1991; 164 5 Pt 2 ; 1390-1396. 39 The European Study Group. Comparative evaluation of cllndamycin gentamicin and cefoxitin doxycycline for treatment of pelvic inflammatory disease: a multi-center trial. Acta Obstetricia et Gynecologica Scandinavica 1992; 71 2 ; : 129-134. 40 Ness RB, Soper DE, Peipert J, Sondheimer SJ, Holley RL, Sweet RL, et al. Design of the PID Evaluation and Clinical Health PEACH ; Study. Controlled Clinical Trials 1998; 19 5 ; : 499-514. 41 Ness RB, Soper DE, Holley RL, Peipert J, Randall H, Sweet RL, et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health PEACH ; Randomized Trial. American Journal of Obstetrics & Gynecology 2002; 186 5 ; : 929-937. 42 Soper DE, Despres B. A comparison of two antibiotic regimens for treatment of pelvic inflammatory disease. Obstetrics & Gynecology 1988; 72 1 ; : 7-12. 43 Hoyme UB, Ansorg R, Von Recklinghausen G, Schindler AE. Quinolones in the treatment of uncomplicated salpingitis: Ofloxacin metronidazole vs. gentamicin clindamicin. Archives of Gynecology & Obstetrics 1993; 254 1-4 ; : 607-608. 44 Landers DV, Wolner-Hanssen P, Paavonen J, Thorpe E, Kiviat N, Ohm-Smith M, et al. Combination antimicrobial therapy in the treatment of acute pelvic inflammatory disease. American Journal of Obstetrics & Gynecology 1991; 164 3 ; : 849-858. 45 Treatment of acute PID: Cefoxitin plus doxycycline versus clindamycin plus tobramycin. Minneapolis, Minnesota, Twenty fifth Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC: American Society for Microbiology; 29th Ocober 1985. 46 Apuzzio JJ, Stankiewicz R, Ganesh V, Jain S, Kaminski Z, Louria D. Comparison of parenteral ciprofloxacin with clindamycin-gentamicin in the treatment of pelvic infection. American Journal of Medicine 1989; 87 5 A ; : 148S-151S. 47 Balbi G, Piscitelli V, Di Grazia F, Martini S, Balbi C, Cardone A. [Acute pelvic inflammatory disease: comparison of therapeutic protocols]. [Italian]. Minerva Ginecologica 1996; 48 1-2 ; : 19-23 and ditropan.
Syndrome and an accelerated rate of ageing with increased risk of cancer, neurodegenerative disorders, allergies, autoimmunity and osteoporosis. The toxins that soldiers were exposed to include: 1. A cocktail of vaccinations given before travel and repeated in Riyadh. It is perfectly possible for these to cause problems because: a ; A large number of vaccines were given up to 14 one day. b ; The vaccinations were given over one to two days which could result in a "cocktail" effect. The synergistic effects of such large cocktails of vaccines has never been studied. c ; Soldiers were very likely to have received vaccinations such as anthrax, which have never undergone proper clinical trials either for efficacy or for tolerance. d ; All vaccinations contain heavy metals which are used as preservatives and immune adjuvants. The most popular is thimerosal which is a mercury compound, but increasingly aluminium hydroxide is being used. It is perfectly possible that so many injections could have resulted in a toxic dose of these toxic metals. e ; Many soldiers had an acute influenza like reaction to both batches of vaccinations with the second being worse than the first. These acute influenza like reactions almost certainly are mediated by cytokines and interferons, suggesting immune reactions and possibly immuno-disruptive effects. 2. As soon as soldiers arrived in Riyadh, they were started on "NAPs" tablets. The drug in NAPs, pyridostigmine, is an antidote to organophosphate poisoning, but it is toxic in its own right. Indeed in normal clinical practice, General Practitioners are not allowed to prescribe this drug. Should it ever be given it always has to be in hospital in a controlled environment where the patient can be carefully observed. 3. Soldiers were very likely to have been exposed to organophosphate chemicals used in chemical warfare. We suspect this because whilst living in the tented city the alarm for chemical contamination was constantly going off. This meant that several times a day they would have to put their gas masks on whilst the alarm was ringing. The Army obviously got fed up with this alarm going off and eventually they told the soldiers that the alarm was malfunctioning and that they did not need to use their gas masks any more. Again this account is supported by "similar fact" witness statements. 4. Whilst living under canvas, these tented cities were regularly sprayed with organophosphates in order to control insects. Anybody living in the area would therefore inevitably have been exposed and indeed it is perfectly possible that the organophosphates used for spraying were responsible for the chemical exposure alarm going off regularly. 5. During the length of their stay in Kuwait there was on-going pollution from oil well fires. The soldiers were constantly exposed to this smoke and indeed veterans have commented that sometimes the day looked like night during when they could only just see the sun. Smoke from burning oil is, of course, extremely toxic for many reasons. First of all it is very likely that combustion was incomplete and therefore would have released polluting gases such as COxs, SOxs and NOxs. These are known irritants to the lung. Secondly, oil well fire smoke would produce many toxic chemicals with a direct irritant, immuno-disruptive and carcinogenic effect. Thirdly, fires would have produced a whole range of particulate matter from the very large particles which would be responsible for the black fog down to very tiny particles of 10 or less. This size of particle is not filtered out by the nose or lungs and would have penetrated deep into the lungs, not only causing lung damage, but also being picked up in the bloodstream where they could have caused arterial and indeed heart damage. 6. There were bombing raids at night and it is known that these bombs were carrying chemical weapons and enalapril.
Under 37 C.F.R. 1.56 b ; , information is material when it is not cumulative of information already of record or being made of record in the application and 1 ; establishes by itself or in combination with other information a prima facie case of unpatentability of a claim or 2 ; it refutes or is inconsistent with, a position the applicant takes in i ; opposing an argument of unpatentability relied on by the USPTO or ii ; asserting an argument of unpatentability.
Risk Assessment FEV-3 ; . clindamycin for penicillin-allergic patients. 1 penicillin V, 6-hourly cephalexin, 6-hourly For mild, early cellulitis where S. pyogenes is confirmed or phenoxymethylpenicillin ; adult: 500 mg orally suspected due to clinical presentation e.g. spontaneous adult: 500 mg orally child: 12.5 mg kg up to 500 mg ; orally rapidly spreading cellulitis ; or local disease patterns e.g. child: 10 mg kg up to indigenous communities in central and northern Australia ; 500 mg ; orally use penicillin V or procaine penicillin. A ; OR Treat other mild early cellulitis with di flucloxacillin B ; -- covers Staphylococcus aureus and S. pyogenes -- unless A ; 1 procaine penicillin, IM daily other causative organisms are suspected e.g. waterImmediate penicillin hypersensitivity adult: 1.5 g related infections, immunocompromised patients ; . child: 50 mg kg up to 1.5 g ; clindamycin, 8-hourly For severe cellulitis intravenous therapy is required. adult: 450 mg orally See Therapeutic Guidelines: Antibiotic 2006 ; B ; di flucloxacillin, child: 10 mg kg up to 450 mg ; orally 6-hourly Cellulitis adult: 500 mg orally child: 12.5 mg kg up to 500 mg ; orally. Your doctor will monitor you closely while you are using clindamycin and clobetasol. What is clindamycin phosphate topical lotionClindamycin hcl 300 mg capran
Clindamycin pads acneLipid management, lumen output chart, fornix of the eye, binge drinking young people australia and pediatrics washington university. Crypt lord, malignant otitis externa treatment, poliomyelitis wiki and glass eye paperweights or provigil glaucoma. Clindamycin im dosageClindamycin suspension strength, dose of clindamycin for aspiration pneumonia, clindamycin colitis, clindamycin urinary infections and what is clindamycin phosphate topical lotion. Clindamycin hcl 300 mg capran, clindamycin pads acne, clindamycin im dosage and gen clindamycin and birth control or clindamycin usages.
© 2007-2009 Val.6te.net -All Rights Reserved. |